“Quick results are crucial in the fight against cancer, and every additional day that a clinician and a patient must wait for test results is a day too long. Roche Diagnostics CEO Michael Heuer said: “The new VENTANA HER2 Dual ISH assay advances Roche’s commitment to personalized healthcare by delivering critical information on treatment options for breast and gastric cancer patients faster. Roche offers a comprehensive menu of both diagnostic and predictive assays, including the Ventana HER2/neu (4B5) rabbit monoclonal primary antibody that will help assess breast cancer patients for whom Herceptin treatment is considered. Herceptin binds to a specific section of the HER2 protein, restricting the signals it sends that advance tumor cell growth and also alerts body’s immune system to attack the cancer cells. The use of pre-diluted VENTANA anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody 1 (VENTANA HER2 (4B5) Antibody), in combination with the fully automated BenchMark IHC/ISH slide staining instrument, standardizes all IHC processes from baking through staining, and reduces the possibility of human error.
Herceptin is a humanized monoclonal antibody, which will target and inhibit the function of the HER2 receptor, a protein found on the outside of many normal cells and in high quantities on the outside of cancer cells in HER2-positive cancers.
The company is also planning to submit an application with the US Food and Drug Administration for approval.
It quickly offers clear results to pathology labs, enabling to make treatment decisions earlier.Īt present, the assay is available in Europe, the Middle East and Africa, as well as Latin America and Asia Pacific. The new Ventana HER2 Dual ISH DNA Probe Cocktail assay can be fully automated on the BenchMark IHC/ISH instruments. Roch claims that it is the only provider of a fully automated brightfield Dual ISH solution to detect HER2 amplification. Biocare UltraLine is a comprehensive antibody portfolio built specifically for your Roche/Ventana BenchMark XT or BenchMark Ultra Instrument. Results can be read using light microscopy, helping to avoid the use of a specialized fluorescence microscope. Ventana HER2 Dual ISH DNA Probe Cocktail assay can be completed within the same day, offering clinicians with quicker results compared to the most common methods of confirmatory testing for HER2. This powerful UltraLine of antibodies is in a convenient ready-to-use format and may be utilized in combination with the Optiview or UltraView Detection Systems. Human epidermal growth factor receptor 2 (HER2) is a significant biomarker observed in breast and gastric cancers. Biocare UltraLine is a comprehensive antibody portfolio built specifically for your Roche/Ventana BenchMark XT or BenchMark Ultra Instrument. Image: The administration and R&D buildings, Roche Diagnostics, Rotkreuz. Device Description: The Ventana MMR IHC panel is comprised of five primary antibodies used to detect the MMR proteins MLH1, PMS2, MSH2 and MSH6 and mutated BRAF V600E protein in CRC tissue specimens.Roche has introduced new Ventana HER2 Dual ISH DNA Probe Cocktail assay to detect HER2 biomarker in breast and gastric cancer patients. Special instrument requirements: Ventana BenchMark Ultra instrument I. What are the special instrument requirements for the ventana benchmark ultra?
Manufacturer: Roche Diagnostics 760219 VENTANA Antibody Diluent with Casein is a buffered, proteinaceous solution containing salt and immunoglobulins used to dilute rabbit and mouse primary antibodies for use on the BenchMark, BenchMark GX, BenchMark XT, and BenchMark ULTRA automated staining platforms. Clear and crisp staining of nuclear or cytoplasmic proteins. However, Ventana supplies a separate blocking kit (cat # 760-050) which can reduce this problem. Choose an option below for immediate access. Our broad portfolio includes VENTANA integrated staining and workflow management platforms, digital pathology solutions and a robust menu of high-medical value assays that help labs increase efficiency, improve patient safety and deliver medical value. ADVERTISEMENT Frequently Asked Questions What does ventana offer? Estrogen Receptor (ER) (SP1) Rabbit Monoclonal Primary Antibody, CONFIRM (250-test) Estrogen Receptor (ER) (SP1) Rabbit Monoclonal Primary Antibody, CONFIRM (50-test) GLIAL Fibrillary Acidic Protein (EP672Y) Rabbit Monoclonal Antibody, CELL MARQUE.
0 kommentar(er)
